BPA Call 36C24222A0001-36C24226N0121

Award Date 10/1/25
Potential Completion Date 9/30/26
Potential Value $50K
Ultimate Awardee
Revvity Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mountain Lakes, NJ 07046, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Veterans Integrated Service Network 2, part of the Department of Veterans Affairs, is for T-SPOT TB reagents and related services. The $69,125.80 firm-fixed-price contract was awarded to Euroimmun US Incorporated, a wholly owned subsidiary of PerkinElmer that manufactures medical diagnostics, with no set-aside designation. The contract has an ultimate completion date of September 30, 2024. Euroimmun has received previous federal contract awards from HHS...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) Call contract to Euroimmun US Incorporated, a wholly owned subsidiary of PerkinElmer, to provide T-SPOT TB Reagents and Test Kits. The contract has a Firm Fixed Price pricing type and a ceiling value of $108,101.00. The ultimate completion date is September 30, 2025. This contract award is not set aside. Euroimmun US Incorporated is the prime contractor, and its parent company is Revvity Inc., which...
This federal contract award, valued at $23,764.50, was made by the Department of Veterans Affairs (VA) to Euroimmun US Incorporated, a subsidiary of PerkinElmer, for the provision of T-SPOT TB reagents. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price. Euroimmun US Incorporated is the prime contractor on this award, which does not have a set-aside designation. The parent company of the prime contractor is Revvity Inc., which has separately received federal awards...
This is a firm-fixed-price blanket purchase agreement (BPA) call contract awarded by the Veterans Health Administration (VHA) of the Department of Veterans Affairs to Oxford Immunotec USA, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC. The contract is for the delivery of T SPOT.TB reagents, an FDA-approved tuberculosis diagnostic test, to the VHA's Veterans Integrated Service Network 2 (VISN 2) covering the New England region. The contract has a ceiling value of $128,337.80 and a...
This federal contract award is for TSPOT TB LABORATORY TESTING SERVICES provided by Quest Diagnostics TB LLC, a for-profit manufacturer of medical laboratory testing and analysis services. The contract, which has a potential value of $305,235.00, was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 and does not have a set-aside designation. Through this firm fixed-price Blanket Purchase Agreement (BPA) call, Quest Diagnostics TB...
The Department of Veterans Affairs (VA) awarded a firm-fixed-price definitive contract to Quest Diagnostics TB LLC, a for-profit manufacturer, to provide TSPOT TB tests. The contract, valued at $123,498.27, was set aside for small businesses and has a completion date of March 31, 2020. The contract was awarded on October 1, 2018 under a solicitation posted on FBO.gov. The contract supports the VA's Veterans Health Administration and Veterans Integrated Service Network 17 in providing...
This is a firm-fixed-price contract awarded by the U.S. Department of Veterans Affairs (VA) to Quest Diagnostics TB LLC, a for-profit manufacturer of medical laboratory testing and analysis services. The contract is for T-SPOT TB testing services and has a ceiling value of $136,349.00. The contract was awarded on December 31, 2015 and has an ultimate completion date of September 30, 2020. The contract is designated as a total small business set-aside. Based on the information provided, Quest...
This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Quest Diagnostics TB LLC, a for-profit manufacturer of medical laboratory testing and analysis services. The contract is for T-SPOT TB testing services under the GSA's Medical Laboratory Testing and Analysis Services schedule. The contract has a ceiling value of $638,309.20 and an ultimate completion date of March 6, 2018. No set-aside designation was used for this award. Quest Diagnostics TB...
This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) under the Medical Laboratory Testing and Analysis Services (FSS-621-II) schedule contract. The prime contractor is Quest Diagnostics TB LLC, a for-profit manufacturer of medical laboratory testing and analysis services. The contract is for tuberculosis (TB) screening and diagnostic testing services, including T-SPOT IGRA TB testing, for various VA medical facilities and the Massachusetts Army National Guard. The...
This is a firm-fixed-price delivery order awarded to Quest Diagnostics TB LLC by the Department of Veterans Affairs (VA) under the GSA's Medical Laboratory Testing and Analysis Services schedule (FSS-621-II). The $76,779.65 contract is for the provision of TSPOT TB test laboratory services. This award is not set aside for small businesses or other socioeconomic categories. Quest Diagnostics TB LLC is a for-profit manufacturer of medical laboratory testing and analysis services that has...
  • 36C24222A0001
    Blanket Purchase Agreement
  • 36C24222A0001-36C24226N0121
    BPA Call

This federal contract award is for T-SPOT TB reagents, which are tuberculosis screening products, under a Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs Veterans Integrated Service Network 2. The prime contractor is Euroimmun US Incorporated, a wholly owned subsidiary of Revvity Inc. (formerly PerkinElmer) that specializes in medical diagnostics and laboratory testing equipment. The contract has a ceiling value of $50,031.40 and a firm fixed-price structure. It does not utilize any set-aside designations. The period of performance runs from October 1, 2025 to September 30, 2026. Euroimmun US has secured multiple federal contract awards from agencies like the Department of Veterans Affairs, Department of Health and Human Services, and Department of the Army, primarily for medical supplies and diagnostic testing equipment. This specific contract expands on Euroimmun's existing Indefinite Delivery Contracts with the Army and VA for immunodiagnostic systems and T-SPOT TB reagents, demonstrating the company's strategic positioning to provide recurring medical diagnostic solutions to federal healthcare and research organizations.

Generated 10/2/25, 10:57 AM